StocktradeC

NKTR short setup

看空
NASDAQ:NKTR   Nektar Therapeutics
NKTR’s innovation outlook is trending down based on a current score of 60 out of 99, outperforming sector average. Insiders sentiment is negative. Over the past 4 quarters NKTR beat earnings estimates 4 times.
For more analysis and articles visit our website.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。